| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 200,538 | 192,887 | 216,731 | 199,868 | | Cost of Revenue | 120,283 | 114,344 | 126,960 | 110,006 | | | Gross Profit | 80,255 | 78,543 | 89,771 | 89,862 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 72,426 | 76,106 | 76,214 | 80,657 | | Non Recurring |
-
| (5,385) |
-
| 314,813 | | Others | 317 | 315 | 308 | (2,635) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,108 | 7,507 | 13,249 | (302,973) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 7,767 | | Earnings Before Interest And Taxes | (5,004) | 7,507 | 13,249 | (295,206) | | Interest Expense | (10,810) | 6,245 | 4,565 | 4,948 | | Income Before Tax | 5,806 | 1,262 | 8,684 | (300,154) | | Income Tax Expense | 1,568 | 729 | 2,172 | (18,577) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,238 | 533 | 6,512 | (281,577) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,238 | 533 | 6,512 | (281,577) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,238 | $533 | $6,512 | ($281,577) |
|
0.11% Nasdaq 0.00%
0.99 (4.55%) 
Income Statement
